amphetamine has been researched along with sch 23390 in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 18 (81.82) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Robbins, TW; Winstanley, CA; Zeeb, FD | 1 |
| Gulley, JM; Hall, DA; Powers, JP | 1 |
| Lin, PJ; Liu, YP; Tseng, CJ; Tung, CS; Wan, FJ | 1 |
| Begović, A; Castner, SA; Selemon, LD; Williams, GV | 1 |
| McGinty, JF; Shi, X | 1 |
| Burgess, CR; Gillis, L; Peever, JH; Tse, G | 1 |
| Kennedy, RT; Li, Q; Mabrouk, OS; Song, P | 1 |
| Lebedev, AA; Shabanov, PD | 1 |
| Kornilov, VA; Lebedev, AA; Liubimov, AV; Shabanov, PD | 1 |
| Cassaday, HJ; Nelson, AJ; Thur, KE | 1 |
| Cocker, PJ; Dinelle, K; Kornelson, R; Sossi, V; Winstanley, CA | 1 |
| Björklund, A; Carta, M; Fidalgo, C; Lisci, C; Shin, E; Stancampiano, R; Tronci, E | 1 |
| Beyer, JD; White, IM; White, W | 1 |
| Czarnecka, A; Konieczny, J; Lenda, T | 1 |
| Fitzgerald, CA; Jin, DZ; Mao, LM; Wang, JQ; Xue, B | 1 |
| Cao, VY; Elkahloun, AG; Liu, Q; Mastwal, S; Ren, M; Wang, KH; Ye, Y; Zhang, W | 1 |
| White, IM; White, W | 1 |
| Antkiewicz-Michaluk, L; Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T | 1 |
| Panlilio, LV; Solinas, M; Wahab, M | 1 |
| Jin, DZ; Mao, LM; Wang, JQ | 1 |
| Liu, Q; Mastwal, S; Wang, KH; Ye, Y; Zhang, W | 1 |
| Chaudhri, N; Khoo, SY; Samaha, AN; Uhrig, A | 1 |
22 other study(ies) available for amphetamine and sch 23390
| Article | Year |
|---|---|
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Choice Behavior; Conditioning, Operant; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Models, Animal; Piperazines; Pyridines; Quinpirole; Rats; Rats, Long-Evans; Reward; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Task Performance and Analysis | 2009 |
Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
Topics: Amphetamine; Analysis of Variance; Animals; Benzazepines; Catheters, Indwelling; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Sulfonamides | 2009 |
Role of dopaminergic DAD1 and DAD2 receptors in the sensitization of amphetamine-suppressed schedule-induced polydipsia in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Locomotion; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2009 |
Reversal of neuronal and cognitive consequences of amphetamine sensitization following chronic treatment with a D1 antagonist.
Topics: Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Cognition; Dendrites; Dendritic Spines; Dopamine Antagonists; Female; Macaca mulatta; Male; Memory, Short-Term; Neurons; Psychomotor Performance; Receptors, Dopamine D1; RNA, Messenger; Signal Transduction | 2010 |
D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats.
Topics: Amphetamine; Animals; Area Under Curve; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; CREB-Binding Protein; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hyperkinesis; Male; Motor Activity; Oncogene Protein v-akt; Phosphoproteins; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Statistics as Topic; Stereotyped Behavior; Time Factors | 2011 |
Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Cataplexy; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Electromyography; Male; Mice; Mice, Knockout; Narcolepsy; Quinpirole; Receptors, Dopamine; Salicylamides; Sleep; Videotape Recording | 2010 |
Microdialysis and mass spectrometric monitoring of dopamine and enkephalins in the globus pallidus reveal reciprocal interactions that regulate movement.
Topics: Amino Acids; Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Drug Interactions; Enkephalin, Leucine; Enkephalin, Methionine; gamma-Aminobutyric Acid; Globus Pallidus; Male; Mass Spectrometry; Microdialysis; Motor Activity; Naloxone; Narcotic Antagonists; Raclopride; Rats; Rats, Sprague-Dawley | 2011 |
[The extended amygdala system and self-stimulation of the lateral hypothalamus in rats: modulation with opiates and opioids].
Topics: Amphetamine; Amygdala; Analgesics, Opioid; Anesthetics, Local; Animals; Barbiturates; Benzazepines; Corticotropin-Releasing Hormone; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enkephalin, Leucine; Fentanyl; Hypnotics and Sedatives; Hypothalamus; Lidocaine; Male; Neuroprotective Agents; Neurotransmitter Agents; Pentobarbital; Peptide Fragments; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Stimulation; Sulpiride | 2011 |
[Significance of CRF and dopamine receptors in amygdala for reinforcing effects of opiates and opioids on self-stimulation of lateral hypothalamus in rats].
Topics: Amphetamine; Amygdala; Analgesics, Opioid; Animals; Benzazepines; Catheterization; Corticotropin-Releasing Hormone; Dopamine; Dopamine Antagonists; Electrodes, Implanted; Fentanyl; Hypothalamus; Male; Narcotics; Peptide Fragments; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Receptors, Dopamine; Self Stimulation; Sulpiride | 2011 |
Dopamine D1 receptor involvement in latent inhibition and overshadowing.
Topics: Amphetamine; Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Dose-Response Relationship, Drug; Inhibition, Psychological; Male; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D1 | 2012 |
Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats.
Topics: Amphetamine; Animals; Autoradiography; Benzazepines; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Dopamine Uptake Inhibitors; Gambling; Individuality; Male; Neostriatum; Positron-Emission Tomography; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D4; Reward; Risk-Taking; Salicylamides; Uncertainty | 2012 |
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
Topics: Amphetamine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Benzazepines; Buspirone; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Mesencephalon; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Receptor Agonists | 2014 |
Acute withdrawal-related hypophagia elicited by amphetamine is attenuated by pretreatment with selective dopamine D1 or D2 receptor antagonists in rats.
Topics: Amphetamine; Analysis of Variance; Animals; Anorexia; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Feeding Behavior; Male; Rats; Rats, Wistar; Salicylamides; Time Factors | 2015 |
Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Amphetamine; Animals; Benzazepines; Central Nervous System Agents; Corpus Striatum; Dopamine; Dopamine Antagonists; Functional Laterality; Glutamic Acid; Haloperidol; Homovanillic Acid; Male; Movement; Parkinsonian Disorders; Rats, Wistar; Receptors, Dopamine; Rotation; Substantia Nigra | 2016 |
Amphetamine elevates phosphorylation of eukaryotic initiation factor 2α (eIF2α) in the rat forebrain via activating dopamine D1 and D2 receptors.
Topics: Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Dopamine D2 Receptor Antagonists; Eukaryotic Initiation Factor-2; Male; Phosphorylation; Prefrontal Cortex; Prosencephalon; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2016 |
Dopamine is Required for Activity-Dependent Amplification of Arc mRNA in Developing Postnatal Frontal Cortex.
Topics: Adrenergic Agents; Age Factors; AIDS-Related Complex; Amphetamine; Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Benzazepines; Dopamine; Dopamine Agents; Dopaminergic Neurons; Electroshock; Frontal Lobe; Gene Expression Regulation, Developmental; Mice; Mice, Inbred C57BL; Microarray Analysis; Oxidopamine; Receptors, Dopamine D1; RNA, Messenger; Ventral Tegmental Area | 2017 |
Amphetamine and morphine may produce acute-withdrawal related hypoactivity by initially activating a common dopamine pathway.
Topics: Amphetamine; Animals; Benzazepines; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Drug Administration Schedule; Male; Morphine; Narcotics; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Time Factors | 2016 |
The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
Topics: Acetylcysteine; Amphetamine; Animals; Apomorphine; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Functional Laterality; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Raclopride; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation | 2017 |
An improved within-session self-adjusting delay discounting procedure for the study of choice impulsivity in rats.
Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; Choice Behavior; Decision Making; Delay Discounting; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Impulsive Behavior; Male; Raclopride; Rats; Receptors, Dopamine D1; Reward | 2018 |
Amphetamine activates non-receptor tyrosine kinase Fyn and stimulates ERK phosphorylation in the rat striatum in vivo.
Topics: Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Dopamine Antagonists; Extracellular Signal-Regulated MAP Kinases; Male; Phosphorylation; Proto-Oncogene Proteins c-fyn; Rats, Wistar; Receptors, Dopamine D1 | 2019 |
Developmental Exposure to Psychostimulant Primes Activity-dependent Gene Induction in Frontal Cortex.
Topics: AIDS-Related Complex; Amphetamine; Analysis of Variance; Animals; Benzazepines; Central Nervous System Stimulants; Chromatin Immunoprecipitation; CREB-Binding Protein; Dopamine; Electric Stimulation; Frontal Lobe; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Signal Transduction; Time Factors | 2019 |
Effects of dopamine receptor antagonism and amphetamine-induced psychomotor sensitization on sign- and goal-tracking after extended training.
Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; Central Nervous System Sensitization; Conditioning, Classical; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Goals; Locomotion; Male; Psychomotor Performance; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Salicylamides | 2021 |